Arrowhead Pharmaceuticals
ARWR
#2048
Rank
โ‚ฌ8.43 B
Marketcap
60,23ย โ‚ฌ
Share price
6.39%
Change (1 day)
433.35%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): โ‚ฌ0.32 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ1.09 Billion. , an increase over its 2024 earnings that were of -โ‚ฌ0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.29 B-157.5%
2024 -โ‚ฌ0.51 Billion112.45%
2023 -โ‚ฌ0.24 Billion87.79%
2022 -โ‚ฌ0.13 Billion-20.1%
2021 -โ‚ฌ0.16 Billion67.59%
2020 -โ‚ฌ95.39 Million-347.53%
2019 โ‚ฌ38.53 M-245.59%
2018 -โ‚ฌ26.47 Million-13.17%
2017 -โ‚ฌ30.49 Million-52.28%
2016 -โ‚ฌ63.89 Million-16.57%
2015 -โ‚ฌ76.57 Million30.32%
2014 -โ‚ฌ58.76 Million171.62%
2013 -โ‚ฌ21.64 Million16.56%
2012 -โ‚ฌ18.56 Million107.53%
2011 -โ‚ฌ8.95 Million
2008 -โ‚ฌ31.5 Million-8.07%
2007 -โ‚ฌ34.27 Million70.37%
2006 -โ‚ฌ20.12 Million122.51%
2005 -โ‚ฌ9.04 Million147.41%
2004 -โ‚ฌ3.66 Million2002.28%
2003 -โ‚ฌ0.18 Million-85.61%
2002 -โ‚ฌ1.21 Million1371.97%
2001 -โ‚ฌ0.09 Million-13.45%
2000 -โ‚ฌ0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.48 B 9,621.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚ฌ2.35 Billion-899.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.13 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ99.88 Million-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.48 B 66.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚ฌ91.76 Million-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA